Updates are available Correction dated 2026-08-24
Click to view Correction: https://doi.org/10.1007/s12325-026-03754-6
-
Authors
Allan, John N.
-
Funding
Funding for this research was provided by:
BeOne Medicines Ltd
- License Information
-
More Information
Article History
Received: 16 October 2025
Accepted: 23 December 2025
First Online: 2 February 2026
Declarations
:
: John N. Allan: Consulting or advisory role: AbbVie, Adaptive Biotechnologies, ADC Therapeutics, AstraZeneca, BeOne Medicines, Ltd, Genentech, Janssen, Lilly, Merck, NeoGenomics, Pharmacyclics; Research funding: BeOne Medicines, Ltd, Celgene/BMS, Genentech; Speakers bureau: AbbVie, BeOne Medicines, Ltd.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by the author.
